C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 277/42 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 31/4439 (2006.01) A61P 3/00 (2006.01) A61P 25/28 (2006.01) C07D 417/06 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2455753
Novel 2,4-diaminothiazole derivatives of the general formula (I) which inhibit GSK-3 (glycogen synthase kinase-3), use of these compounds as medicaments, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds may be useful for the treatment of disorders, syndromes, diseases and conditions, wherein an inhibition of GSK-3 (glycogen synthase kinase-3) is beneficial, especially IGT (impaired glucose tolerance), type 1 diabetes, type 2 diabetes, obesity, Alzheimer's disease and bipolar disorder.
L'invention porte: sur de nouveaux dérivés de la 2,4-diaminothiazole de formule générale (I) inhibiteurs de la GSK-3 (glycogène synthase kinase-3), sur l'utilisation de ces composés comme médicaments; sur des préparations pharmaceutiques les contenant et sur des procédés de traitement utilisant lesdits composés et compositions. Lesdits composés peuvent servir à traiter des troubles, syndromes, maladies et états où l'inhibition de la GSK-3 (glycogène synthase kinase-3) est bénéfique, et spécialement: la diminution de la tolérance au glucose, le diabète de type 1, le diabète de type 2, l'obésité, la maladie d'Alzheimer et les troubles bipolaires.
Bowler Andrew Neil
Hansen Bo Falck
Mccarthy Tetrault Llp
Novo Nordisk A/s
LandOfFree
Novel 2,4-diaminothiazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel 2,4-diaminothiazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel 2,4-diaminothiazole derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1774060